Wednesday, April 01, 2020 9:22:15 AM
Couldn't agree more Looking4aprofit
After what happened with Woodford, there is no way on earth LP would have let Duffy anywhere near her secret sauce unless it was nailed down that he could not take that information elsewhere.
Thats why I believe a deal, be it BO or partnership, has already been agreed in principle.
If I remember rightly, Basin Street Blues was being adamant that a deal was already done back in Nov 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145129896
I believe LP would not sell at a low offer and BP (Merck) would not buy at high offer until approval
As we were nearing approval I think LP was offered help (Duffy) to get to that stage (before another BP trys to make a move)
Also whilst here at NWBO he had chance to validate the chances of Direct gaining approval.
To me the big question is, why did Merck keep his job open for so long. Surely a company needs to fill vital positions as quickly as possible, so as not to impeed progress.
JMHO but with Sawston, Bosche going to Netherlands, Duffy moving back to Merck, it all seems to fit that something big is about to happen very soon
GLTAL.
After what happened with Woodford, there is no way on earth LP would have let Duffy anywhere near her secret sauce unless it was nailed down that he could not take that information elsewhere.
Thats why I believe a deal, be it BO or partnership, has already been agreed in principle.
If I remember rightly, Basin Street Blues was being adamant that a deal was already done back in Nov 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145129896
I believe LP would not sell at a low offer and BP (Merck) would not buy at high offer until approval
As we were nearing approval I think LP was offered help (Duffy) to get to that stage (before another BP trys to make a move)
Also whilst here at NWBO he had chance to validate the chances of Direct gaining approval.
To me the big question is, why did Merck keep his job open for so long. Surely a company needs to fill vital positions as quickly as possible, so as not to impeed progress.
JMHO but with Sawston, Bosche going to Netherlands, Duffy moving back to Merck, it all seems to fit that something big is about to happen very soon
GLTAL.
DCVax could well be the biggest medical breakthrough - EVER
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
